Abiopharma

WORTHINGTON ENTERPRISES, INC. (WOR) Announces Business Combination WORTHINGTON ENTERPRISES, INC. (WOR) has entered into a strategic transaction. Transaction Details:

• Target Company: use of proceeds the proceeds of the fifth amended and restated credit agreement may be used to repay existing indebtedness and for working capital and other general corporate purposes, including capital expenditures and
• Purchase Price: $500
  • looking statements,” as that term is used in the Private Securities Litigation Reform Act of 1995 (the “Act”). We wish to take advantage of the safe harbor provisions included in the Act. Forward
  • looking statements reflect our current expectations, estimates or projections concerning future results or events. These statements are often identified by the use of forward
  • looking words or phrases such as “believe,” “expect,” “anticipate,” “may,” “could,” “should,” “would,” “intend,” “plan,” “will,” “likely,” “estimate,” “project,” “position,” “strategy,” “target,” “aim,” “seek,” “foresee” and similar words or phrases. These forward